BioCentury
ARTICLE | Clinical News

Isis regulatory update

February 12, 1996 8:00 AM UTC

ISIP received U.S. Patent No. 5,489,677 covering methylene methyl imino (MMI) and related chemical constructs used to link together the bases in antisense drugs. MMI linkage allows the creation of bac...